Federal regulatory issues: investigational new drugs in ophthalmology.
Boyd
William B
WB
Food and Drug Administration's Center for Drug Evaluation and Research in the Division of Anti-inflammatory, Analgesic, and Ophthalmologic Drug Products, USA.
D015507:Drugs, Investigational; D006801:Humans; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug; D009885:Ophthalmology / Q000331:legislation & jurisprudence*; D014481:United States
D015507:Drugs, Investigational